ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
38 announcements with these filters
PVP Ventures intimated a board meeting on 13 November 2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. The trading window stays closed until 48 hours after the results are declared.
PVP Ventures won a ₹142.15 Crore order from Sweden's Elekta Solutions AB for 10 HARMONY LINAC systems. Phased delivery is expected by October 2028.
Evervie Health Limited signed an LOI to procure 10 LINAC systems from Elekta Solutions AB, valued at approximately $11–15 million (₹104.5–142.5 Crore).
Everyvie Health (formerly PVP Ventures) filed its Reg 76 share capital reconciliation report for Q2 FY27. No transaction or capital change is reported for the quarter.
Evervie Health Limited made an advance interest payment of ₹13.46 Crore on its Non-Convertible Debentures, fulfilling its debt obligations for future scheduled payment dates.
Evervie Health Limited submitted an updated Annual Report for FY 2025-26. This filing incorporates an addendum and corrigendum to the previously submitted report.
PVP Ventures Limited has officially changed its name to Evervie Health Limited, effective from 5th October, 2026, following approval from the Registrar of Companies.
PVP Ventures paid interest on non-convertible debentures on October 3, 2026. The total interest payment amounted to Rs. 1.04 Crore.
Dr. Ellen Jane Feehan has resigned as Executive Director and CEO of PVP Ventures Ltd due to personal health reasons, effective September 24, 2026.
PVP Ventures Ltd has fixed September 23, 2026, as the record date for interest payments on its Non-Convertible Debentures, payable on October 8, 2026.
PVP Ventures filed the summary of proceedings of its 35th AGM held on 7 Sep 2026. All business items were transacted and voting results await declaration within two working days.
PVP Ventures Ltd announced the resignation of Company Secretary and Compliance Officer Mr. B Vignesh Ram, effective September 11, 2026. The Board accepted it for personal reasons.
PVP Ventures' board appointed Vinay Paruchuru as Company Secretary and accepted B Vignesh Ram's resignation, effective September 2026. No financial impact is associated with this governance change.
Acuité Ratings & Research Limited has assigned an 'ACUITE BBB-|Stable' credit rating to PVP Ventures Limited's Non-Convertible Debentures. This reflects the company's current credit profile.
PVP Ventures issued a corrigendum to its 35th AGM notice, adding 'Re-appointment' to the resolution regarding managerial remuneration for its Chairman and Managing Director.
PVP Ventures Ltd has dispatched the Annual Report FY 2025-26 access link to unregistered shareholders, in compliance with SEBI Listing Regulations.
PVP Ventures Limited filed its Annual Report for FY 2025-26. The company also announced its 35th Annual General Meeting to be held on September 7, 2026.
PVP Ventures Limited will hold its 35th Annual General Meeting on September 7, 2026. The agenda includes financial statements, director appointments, ESOP approval, and name change.
PVP Ventures announced the resignations of Non-Executive Independent Director Kushal Kumar and Executive Director Dileep Badey. Both departures are effective August 14, 2026.
PVP Ventures Ltd reported revenue from operations of ₹45.6 Cr (+165.1% YoY) and net profit of ₹11.1 Cr for Q1 FY27.
PVP Ventures Limited scheduled a board meeting on August 14, 2026, to approve the standalone and consolidated financial results for the quarter ended June 30, 2026.
PVP Ventures Limited clarified that recent increases in trading volume are purely market-driven. The company confirmed there is no undisclosed material information or impending announcements.
PVP Ventures filed its Reconciliation of Share Capital Audit Report for the quarter ended June 30, 2026, as required by SEBI regulations.
PVP Ventures confirmed payment of interest on its non-convertible debentures. The total interest payout amounts to approximately ₹4.00 Crore.
PVP Ventures Ltd has submitted its quarterly shareholding pattern disclosure for the period ending June 30, 2026, in compliance with SEBI regulations.
PVP Ventures fixed July 20, 2026, as the record date for NCD interest payments. Payments are scheduled for July 21, 2026.
PVP Ventures completed acquiring 4,263 shares in 7 Med India Pvt Ltd for ₹127 Cr, raising its stake to 41.23%. The deal advances its healthcare sector expansion.
PVP Ventures Ltd deferred repayment of its non‑convertible debentures to June 2027. The amendment, filed under Regulation 51, updates the Debenture Trust Deed.
PVP Ventures Limited paid Rs.3.50 Crore interest on its Non-Convertible Debentures. Payments were completed on June 24, 2026.
PVP Ventures Ltd reported revenue from operations of ₹41.4 Cr (+117.9% YoY) and a net loss of ₹3.2 Cr for Q4 FY26.